The Health Secretary is to sign a memorandum of understanding with BioNTech, which still explore personalised mRNA thereapies, such as cancer vaccines.
The Department of Health and Social Care today announced a formal collaboration with
Currently 1 in 2 people in the UK gets cancer during their lifetime. Every year, almost 400,000 new cases are diagnosed, and cancer costs the NHS £7 billion annually. The agreement means that cancer patients will get "early access to trials exploring personalised mRNA therapies, like cancer vaccines". Trials for innovative treatments could start as early as autumn 2023 and have "the potential to transform outcomes for cancer patients", the DHSC said.
"Building on the lessons learnt during the pandemic - including the development of a COVID-19 vaccine - the partnership will enable the government and BioNTech to harness the country’s world-leading expertise in organisations such as the National Institute for Health and Care Research and Genomics England.
In addition, "the company will strengthen its UK footprint by setting up a regional headquarter in London to accommodate employees in global and regional supporting functions, including regulatory, medical, intellectual property, and legal". As part of the agreement, BioNTech will remain the local sponsor of current and upcoming new clinical trials of its programs in the UK, and will design the clinical trial protocols.
"Our goal is to accelerate the development of immunotherapies and vaccines using technologies we have been researching for over 20 years. The collaboration will cover various cancer types and infectious diseases affecting collectively hundreds of millions of people worldwide.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New cancer vaccine makes cancer cells kill their own familyScientists tested a dual-action brain cancer vaccine in mice. The vaccine used active cancer cells to kill existing tumors and delivered promising results.
Read more »
Revolutionary Cancer Vaccine Simultaneously Kills and Prevents Brain TumorsDual-action cell therapy engineered to eliminate established tumors and train the immune system to eradicate primary tumor and prevent cancer’s recurrence. Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS,
Read more »
Boston cancer researchers create vaccine to kill and prevent brain cancer glioblastomaBrigham and Women’s Hospital researchers have created a cancer vaccine to simultaneously kill and prevent the deadly brain cancer glioblastoma.
Read more »
Boston cancer researchers create vaccine to kill and prevent brain cancer glioblastomaBrigham and Women’s Hospital researchers have created a cancer vaccine to simultaneously kill and prevent the deadly brain cancer glioblastoma.
Read more »
Peugeot Inception is 671bhp super-GT to preview new EVs | AutocarPeugeot has revealed its extraordinary new Inception concept which it says 'heralds a new era' for future Peugeot electric cars ⚡ What do you think?
Read more »
Cancer vaccines being developed at the Tisch Cancer Institute at Mount SinaiResearchers in New York are doing work on developing cancer vaccines.
Read more »